跳至主要内容
临床试验/NCT06906055
NCT06906055尚未招募不适用

Below-the-Knee Interventions for Limb Salvage: Use of Multifunctional Angioplasty Balloon Catheters

Summa Therapeutics, LLC2 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2025年4月3日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
24
试验地点
2
主要终点
Contrast volume

研究概览

简要总结

Below-the-Knee Interventions for Limb Salvage: Use of Multifunctional Angioplasty Balloon Catheters ("BTK Multicath Registry")

A non-randomized clinical registry

This study is designed to obtain preliminary data on clinically relevant procedural variables during percutaneous below-knee artery revascularization procedures among consecutive patients treated with either the Finesse BTK Multicath® ("Finesse") or the standard of care using conventional angioplasty balloon catheters.

This registry will enroll participants with a history of chronic limb threatening ischemia and below-knee arterial insufficiency who will be assigned to revascularization with or without use of the Finesse BTK Multicath. The registry is an acute study examining procedural data only. The primary endpoints of interest are the volume of contrast used for the intervention, overall procedure time, radiation dose, number of catheter exchanges during revascularization, and medical device supply costs. For the first phase 12 consecutive patients will be treated with the standard of care. For the second phase 12 consecutive patients will be treated with Finesse.

24 participants total

Up to 5 study sites in the United States

Initial anticipated enrollment: Q4 2024 Last anticipated enrollment: Q2 2025

Patients >=18 years old with documented history of unilateral chronic limb threatening ischemia due to below-knee arterial insufficiency with angiographic runoff in the foot and limited arterial insufficiency above the knee

  1. Contrast volume administered during the revascularization portion of a procedure.
  2. Number of catheter exchanges during revascularization
  3. Fluoroscopy time
  4. Radiation dose during revascularization
  5. Procedure time post-enrollment
  6. Equipment costs
  7. Reduced use of supplies
  8. Technical success
  9. Safety/Major Adverse Peripheral Events

On-treatment sample Intention-to-treat

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 120 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Participant must provide written informed consent prior to any clinical investigation-related procedures.
  • •Age ≥ 18 years
  • •Planned lower extremity catheter-based revascularization for Rutherford 4 through 6 chronic limb-threatening ischemia (Table 1)
  • •Stenotic (>=70% stenosis by visual estimate) or occlusive lesion in an infrapopliteal artery (anterior tibial, peroneal, or posterior tibial) by angiography
  • •Target lesion up to 25cm in length by angiography

排除标准

  • •Participation in another clinical investigation that has not yet completed its primary end point.
  • •Incapacitated individuals, defined as persons who are mentally ill, mentally handicapped, or individuals without legal authority, are excluded from the study population.
  • •Female subjects of childbearing potential unless negative pregnancy test or contraceptive use
  • •Bilateral critical limb ischemia
  • •Planned bilateral vascular intervention
  • •Lack of reconstitution of foot runoff vessels at ankle joint
  • •Planned below-the-ankle intervention after completion of diagnostic angiography
  • •Planned suprainguinal intervention ->=5cm with at least 50% stenosis of the above knee femoro-popliteal artery

研究组 & 干预措施

Standard of care

Active Comparator

Use of conventional single function crossing catheters, diagnostic catheters, angioplasty balloon catheters

干预措施: Standard of Care (SOC) (Device)

Finesse BTK Multicath

Experimental

Use of a multifunctional revascularization catheter

干预措施: Multicath (Device)

结局指标

主要结局

Contrast volume

时间窗: during the intervention/procedure/surgery

次要结局

未报告次要终点

研究者

发起方
Summa Therapeutics, LLC
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验